Fig. 2From: The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in ChinaKaplan-Meier analysis (A) Comparison of PFS between ROS1 rearranged NSCLC patients receiving ROS1 TKIs with and without TEEs (P = 0.0383). (B) Comparison of OS between ROS1 rearranged NSCLC patients with or without TEEs (P = 0.0647)Back to article page